Venous thrombosis in patients with high-grade glioma.
Fiche publication
Date publication
novembre 2015
Journal
Current opinion in oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr TAILLANDIER Luc
Tous les auteurs :
Taillibert S, Taillandier L, Le Rhun E
Lien Pubmed
Résumé
High-grade glioma (HGG) patients are at particularly high risk of venous thromboembolism (VTE) occurrence and recurrence. VTE is associated with worsened survival in these patients. At present, the main challenge when prescribing anticoagulants in HGG patients is to address the risk of intracranial hemorrhage and provide the optimal treatment.
Mots clés
Anticoagulants, adverse effects, Antineoplastic Agents, therapeutic use, Biomarkers, analysis, Brain Neoplasms, complications, Glioma, complications, Humans, Incidence, Intracranial Hemorrhages, chemically induced, Risk Factors, Venous Thromboembolism, diagnosis
Référence
Curr Opin Oncol. 2015 Nov;27(6):516-21